Short answer: they’re not the same. DayVigo (lemborexant) and trazodone are used for insomnia, but they work very differently and have different safety and dosing patterns. DayVigo is a targeted sleep medication approved specifically for insomnia; trazodone is an antidepressant (often used off-label for sleep) with a broader side‑effect profile.
Key differences
- Mechanism
- DayVigo: dual orexin receptor antagonist (orexin A and B pathways) that promotes sleep by reducing wake signals.
- Trazodone: serotonin antagonist and reuptake inhibitor (SARI) with modest sedating effects; not a sleep-targeted agent.
- Indication and evidence
- DayVigo: approved specifically for insomnia (sleep onset and maintenance). Backed by trials showing improvements in time to sleep onset and wake after sleep onset.
- Trazodone: not approved for insomnia in most places; often prescribed off-label for sleep, especially when mood symptoms (depression, anxiety) coexist. Evidence for sleep improvement is mixed and less robust than for dedicated sleep meds.
- Typical dosing
- DayVigo: 5 mg or 10 mg taken within about 30 minutes of bedtime; start at 5 mg and may increase to 10 mg if needed. Maximum recommended dose is 10 mg.
- Trazodone: commonly 25–100 mg at bedtime for sleep (often 50–100 mg). Dosing is highly individualized and higher doses are used for depression.
- Side effects and safety
- DayVigo: common: somnolence, dizziness, headache, fatigue; may cause next-day impairment; rare sleep-related behaviors. Low abuse potential compared with benzodiazepines or Z-drugs. Interactions: strong CYP3A inhibitors/inducers can require dose changes or avoidance; caution in hepatic impairment.
- Trazodone: common: drowsiness, dizziness, dry mouth, orthostatic hypotension; risk of morning grogginess and falls, especially in older adults. Rare but serious: priapism (medical emergency); potential QT prolongation; hyponatremia in older adults; interactions with other sedatives and QT-prolonging drugs.
- Special considerations
- Elderly: both can increase fall risk, but trazodone’s blood-pressure effects and daytime grogginess can be problematic. DayVigo may cause less daytime sedation than some sedative-hypnotics but can still impair function the next day.
- Mood disorders: trazodone can help if depressive symptoms are present; DayVigo has no antidepressant effect.
- Pregnancy: consult a clinician; discuss risks with your healthcare provider.
- Sleep architecture and behavior: rare but serious sleep behaviors have been reported with orexin antagonists; monitor for unusual sleep events.
Bottom line
- If your primary problem is genuine insomnia and you want a sleep-specific medication with a targeted mechanism and a relatively favorable daytime safety profile, DayVigo is often preferred.
- If you have coexisting depression or anxiety, need a cheaper option, or DayVigo isn’t tolerated or contraindicated, trazodone is commonly used off-label, but it brings more potential side effects (especially daytime grogginess and blood pressure effects) and has different safety considerations.
If you’re weighing these for yourself, a clinician will consider your health history, other meds (including CYP3A inhibitors/inducers), liver function, fall risk, and whether you have mood symptoms.
Would you like a quick comparison tailored to your situation (age, other meds, liver/kidney issues, history of depression or anxiety, risk of falls)?